Related Experiment Video
Updated: May 20, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic
Jason P Covy1, Elisa A Waxman, Benoit I Giasson
1Department of Cellular and Molecular Physiology, Stanford University, Stanford, California, USA.
Abstract:
Mutations in ATP13A2, which encodes a lysosomal P-type ATPase of unknown function, cause an autosomal recessive parkinsonian syndrome. With mammalian cells, we show that ATP13A2 expression protects against manganese and nickel toxicity, in addition to proteasomal, mitochondrial, and oxidative stress. Consistent with a recessive mode of inheritance of gene defects, disease-causing mutations F182L and G504R are prone to misfolding and do not protect against manganese and nickel toxicity because they are unstable as a result of degradation via the endoplasmic reticulum-associated degradation (ERAD)-proteasome system. The protective effects of ATP13A2 expression are not due to inhibition of apoptotic pathways or a reduction in typical stress pathways, insofar as these pathways are still activated in challenged ATP13A2-expressing cells; however, these cells display a dramatic reduction in the accumulation of oxidized and damaged proteins. These data indicate that, contrary to a previous suggestion, ATP13A2 is unlikely to convey cellular resilience simply by acting as a lysosomal manganese transporter. Consistent with the recent identification of an ATP13A2 recessive mutation in Tibetan terriers that develop neurodegeneration with neuronal ceroid lipofucinoses, our data suggest that ATP13A2 may function to import a cofactor required for the function of a lysosome enzyme(s).
Insights
Mutations in ATP13A2 cause parkinsonism by impairing cellular protection. This study reveals ATP13A2 protects against heavy metal and oxidative stress, suggesting a role in lysosomal function.
Area of Science:
- Cell Biology
- Neurogenetics
- Biochemistry
Background:
- Mutations in ATP13A2 are linked to autosomal recessive parkinsonian syndrome.
- The precise function of ATP13A2, a lysosomal P-type ATPase, remains largely unknown.
- Understanding ATP13A2's role is crucial for neurodegenerative disease research.
Purpose of the Study:
- To elucidate the cellular function of ATP13A2.
- To investigate the impact of disease-associated mutations on ATP13A2 function and stability.
- To determine the protective mechanisms conferred by ATP13A2 expression.
Main Methods:
- Mammalian cell culture expressing wild-type and mutant ATP13A2.
- Assessment of cellular protection against manganese, nickel, proteasomal, mitochondrial, and oxidative stress.
- Analysis of protein stability and degradation pathways, including endoplasmic reticulum-associated degradation (ERAD).
Main Results:
- ATP13A2 expression confers significant protection against manganese, nickel, and various cellular stresses.
- Disease-associated mutations (F182L, G504R) lead to protein misfolding and instability, abrogating protective functions.
- Protective effects are not mediated by apoptosis inhibition but by reducing oxidized/damaged protein accumulation.
- ATP13A2 is unlikely to function solely as a manganese transporter.
Conclusions:
- ATP13A2 plays a vital role in cellular resilience against diverse toxic insults.
- Misfolding and ERAD-mediated degradation of mutant ATP13A2 underlie its loss-of-function in parkinsonism.
- ATP13A2 may function in cofactor import for lysosomal enzymes, contributing to neuronal health.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Parkinson Disease ll: Pathophysiology
ATP Synthase: Mechanism
Cell Specific Gene Expression
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
